Metoclopramide as Prophylaxis for Nausea and Vomiting Induced by Fluorescein
- 1 May 1987
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 105 (5) , 658-659
- https://doi.org/10.1001/archopht.1987.01060050076041
Abstract
• Fluorescein angiography carries with it a variable incidence of nausea and vomiting. We investigated a method of prophylaxis against this side effect. One hundred patients undergoing fluorescein angiography were pretreated in a doublemasked, randomized fashion with either 20 mg of intravenous metoclopramide hydrochloride or an equal volume of normal saline soution. The metoclopramidetreated group demonstrated a statistically significant decrease in the incidence of nausea and vomiting. Eleven (22%) of the control group and three (6%) of the metoclopramide-treated group had this complication. Metoclopramide is an effective drug when used prophylactically in selected patients undergoing fluorescein angiography.This publication has 8 references indexed in Scilit:
- Subretinal Hemorrhage During Fluorescein AngiographyAmerican Journal of Ophthalmology, 1987
- Metoclopramide: Pharmacology and Clinical ApplicationAnnals of Internal Medicine, 1983
- Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and VomitingNew England Journal of Medicine, 1981
- The substituted benzamides - a novel class of dopamine antagonistsLife Sciences, 1979
- Reactions Following Intravenous FluoresceinAmerican Journal of Ophthalmology, 1971
- The action of metoclopramide on human gastroduodenal motilityGut, 1971
- Effect of metoclopramide on gastric function in manGut, 1969